Similar drugsTo uncover
Dosage form: & nbsphomeopathic dissolving tablets
Composition:
Composition: (per one tablet)
Active components:
Aconitum napellus (aconite napellus) C6 0.5 mg
Belladonna (belladonna) C6 0.5 mg
Calendula officinalis (Calendula officinalis) C6 0.5 mg
Chelidoniuin majus (chelidonium mayus) C6 0.5 mg
Jequirity (eqvirity) C6 0.5 mg
Viburnum opulus (viburnum thickus) C6 0.5 mg
Auxiliary components:
sucrose 225 mg;
lactose 72 mg;
magnesium stearate 3 mg.
Description:Round tablets of biconvex form of white color, with engraving "SEDATIF RS" on one side, odorless or with a faint odor.
Pharmacotherapeutic group:Homeopathic Remedy
ATX: & nbsp
  • Other medications
  • Pharmacodynamics:Multicomponent homeopathic remedy, the effect of which is due to its constituent components.
    Indications:Anxiety disorders, anxiety, sleep disturbance.
    Contraindications:
    Anxiety disorders of severe severity. Children up to 3 years. Increased individual sensitivity to individual components of the drug.
    Pregnancy and lactation:The drug is used after consultation with a doctor.
    Dosing and Administration:Inside. Slowly dissolve 2 tablets 3 times a day. Children up to 6 years old before taking the solution to dissolve tablets in water. Duration of treatment is 7-14 days according to the doctor's recommendation.The drug should not take more than two weeks. Thus it is necessary to consult with the doctor in case the symptoms intensify or do not stop after 7 days of treatment.
    Side effects:At the moment there is no information on the side effects of the drug. If side effects occur, consult a doctor.
    Overdose:Cases of overdose have not been registered to date
    Interaction:
    At the moment, there is no interaction with other drugs.
    The intake of homeopathic preparations does not exclude the treatment with other medications.
    Special instructions:
    It is necessary to consult your doctor if no improvement is noted on the background of taking the drug.
    If there is an identified intolerance to fructose, sucrose or galactose, glucose malabsorption syndrome, galactose or a sugarase / isomaltase deficiency, the drug should not be taken because it contains sucrose and lactose.
    Patients suffering from diabetes should take into account that each tablet contains less than 0.02 "bread units" (XE).
    Effect on the ability to drive transp. cf. and fur:Does not affect.
    Form release / dosage:Homoepatic resorption tablets.
    Packaging:For 20 tablets in a blister of PVC film and lacquered aluminum foil. For 2 blisters (20 tablets each), along with the instructions for use are placed in a cardboard box.
    Storage conditions:At a temperature of no higher than 25 ° C. Keep out of the reach of children.
    Shelf life:
    5 years. Do not use after the expiry date printed on the package.
    Terms of leave from pharmacies:Without recipe
    Registration number:LSR-006558/09
    Date of registration:17.08.2009 / 12.04.2017
    Expiration Date:Unlimited
    The owner of the registration certificate:BUARONBUARON France
    Manufacturer: & nbsp
    BOIRON France
    Representation: & nbspBUARON LLCBUARON LLCFrance
    Information update date: & nbsp04.05.2017
    Illustrated instructions
      Instructions
      Up